Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephanie Lheureux

Showing results (11-20 of 144) with videos related to

Pageof 15
Sort By:
Future Oncology (London, England)|November 30, 2020
Dostarlimab in the treatment of recurrent or primary advanced endometrial cancerLawrence Kasherman, Soha Ahrari, Stephanie Lheureux
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 13, 2019
The DNA Repair Pathway as a Target for Novel Drugs in Gynecologic CancersStephanie Lheureux, Mansoor Mirza, Robert Coleman
CA: a Cancer Journal for Clinicians|May 18, 2019
Epithelial ovarian cancer: Evolution of management in the era of precision medicineStephanie Lheureux, Marsela Braunstein, Amit M Oza
Expert Opinion on Pharmacotherapy|March 17, 2017
Niraparib for the treatment of ovarian cancerYada Kanjanapan, Stephanie Lheureux, Amit M Oza
Drug Design, Development and Therapy|April 3, 2018
Rucaparib: a novel PARP inhibitor for <i>BRCA</i> advanced ovarian cancerIlaria Colombo, Stephanie Lheureux, Amit Manulal Oza
Expert Opinion on Investigational Drugs|April 11, 2014
Recent and current Phase II clinical trials in endometrial cancer: review of the state of artStephanie Lheureux, Michelle Wilson, Helen J Mackay
Cancers|March 27, 2019
Tailoring Ovarian Cancer Treatment: Implications of <i>BRCA1/2</i> MutationsAinhoa Madariaga, Stephanie Lheureux, Amit M Oza
Current Opinion in Obstetrics & Gynecology|December 13, 2016
Treatment strategies for endometrial cancer: current practice and perspectiveYeh C Lee, Stephanie Lheureux, Amit M Oza
Cancer|June 1, 2026
Antibody-drug conjugates in gynecologic cancersArantzazu Barquin, Lawrence Kasherman, Stephanie Lheureux, et al.
Future Oncology (London, England)|June 2, 2018
The role of niraparib for the treatment of ovarian cancerJosee-Lyne Ethier, Stephanie Lheureux, Amit M Oza
Pageof 15

Showing results (11-20 of 144) with videos related to

Sort By:
Pageof 15
Future Oncology (London, England)|November 30, 2020
Dostarlimab in the treatment of recurrent or primary advanced endometrial cancerLawrence Kasherman, Soha Ahrari, Stephanie Lheureux
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 13, 2019
The DNA Repair Pathway as a Target for Novel Drugs in Gynecologic CancersStephanie Lheureux, Mansoor Mirza, Robert Coleman
CA: a Cancer Journal for Clinicians|May 18, 2019
Epithelial ovarian cancer: Evolution of management in the era of precision medicineStephanie Lheureux, Marsela Braunstein, Amit M Oza
Expert Opinion on Pharmacotherapy|March 17, 2017
Niraparib for the treatment of ovarian cancerYada Kanjanapan, Stephanie Lheureux, Amit M Oza
Drug Design, Development and Therapy|April 3, 2018
Rucaparib: a novel PARP inhibitor for <i>BRCA</i> advanced ovarian cancerIlaria Colombo, Stephanie Lheureux, Amit Manulal Oza
Expert Opinion on Investigational Drugs|April 11, 2014
Recent and current Phase II clinical trials in endometrial cancer: review of the state of artStephanie Lheureux, Michelle Wilson, Helen J Mackay
Cancers|March 27, 2019
Tailoring Ovarian Cancer Treatment: Implications of <i>BRCA1/2</i> MutationsAinhoa Madariaga, Stephanie Lheureux, Amit M Oza
Current Opinion in Obstetrics & Gynecology|December 13, 2016
Treatment strategies for endometrial cancer: current practice and perspectiveYeh C Lee, Stephanie Lheureux, Amit M Oza
Cancer|June 1, 2026
Antibody-drug conjugates in gynecologic cancersArantzazu Barquin, Lawrence Kasherman, Stephanie Lheureux, et al.
Future Oncology (London, England)|June 2, 2018
The role of niraparib for the treatment of ovarian cancerJosee-Lyne Ethier, Stephanie Lheureux, Amit M Oza
Pageof 15